blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1787998

EP1787998 - ANTIBODY AND UTILIZATION OF THE SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.07.2011
Database last updated on 18.09.2024
Most recent event   Tooltip29.07.2011Application deemed to be withdrawnpublished on 31.08.2011  [2011/35]
Applicant(s)For all designated states
Mitsubishi Chemical Corporation
14-1, Shiba 4-chome Minato-ku
Tokyo 108-0014 / JP
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
[N/P]
Former [2008/23]For all designated states
Mitsubishi Chemical Corporation
14-1, Shiba 4-chome, Minato-ku
Tokyo 108-0014 / JP
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Former [2007/21]For all designated states
Mitsubishi Chemical Corporation
14-1, Shiba 4-chome, Minato-ku
Tokyo 108-0014 / JP
For all designated states
Mitsubishi Pharma Corporation
6-9, Hiranomachi 2-chome, Chuo-ku Osaka-shi
Osaka 541-0046 / JP
Inventor(s)01 / HOSHI, Minako, MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES
11, Minamiooya
Machida-shi, Tokyo 194-8511 / JP
02 / NAITO, Koji, MITSUBISHI PHARMA CORPORATION, Tokyo Office
2-6, Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo 1038405 / JP
03 / IDENO, Shouji, MITSUBISHI PHARMA CORPORATION, Tokyo Office
2-6, Nihonbashi-honcho 2-chome, Chuo-ku
Tokyo 1038405 / JP
 [2007/21]
Representative(s)Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Strasse 4
80335 München / DE
[N/P]
Former [2007/21]TER MEER - STEINMEISTER & PARTNER GbR
Mauerkircherstrasse 45
81679 München / DE
Application number, filing date05770817.411.08.2005
[2007/21]
WO2005JP14735
Priority number, dateJP2004023485711.08.2004         Original published format: JP 2004234857
[2007/21]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006016644
Date:16.02.2006
Language:EN
[2006/07]
Type: A1 Application with search report 
No.:EP1787998
Date:23.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 16.02.2006 takes the place of the publication of the European patent application.
[2007/21]
Search report(s)International search report - published on:JP16.02.2006
(Supplementary) European search report - dispatched on:EP29.07.2008
ClassificationIPC:C07K16/18, A61K39/395, A61P25/28, A61P43/00, G01N33/15, G01N33/50, G01N33/53
[2007/21]
CPC:
C07K16/18 (EP,KR,US); A61K39/395 (KR); A61P25/28 (EP);
A61P43/00 (EP); C07K16/00 (KR); G01N33/6893 (EP,US);
A61K2039/505 (EP,US); G01N2800/2821 (EP,US); Y10S530/809 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/21]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ANTIKÖRPER UND DEREN VERWENDUNG[2007/21]
English:ANTIBODY AND UTILIZATION OF THE SAME[2007/21]
French:ANTICORPS ET UTILISATION S'Y RAPPORTANT[2007/21]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase23.02.2007Translation filed 
23.02.2007National basic fee paid 
23.02.2007Search fee paid 
23.02.2007Designation fee(s) paid 
23.02.2007Examination fee paid 
Examination procedure23.02.2007Examination requested  [2007/21]
17.10.2008Despatch of a communication from the examining division (Time limit: M08)
23.06.2009Reply to a communication from the examining division
13.10.2010Despatch of a communication from the examining division (Time limit: M04)
24.02.2011Application deemed to be withdrawn, date of legal effect  [2011/35]
31.03.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/35]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.10.2008
Fees paidRenewal fee
23.02.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
12.08.2009Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.08.201006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0072880  (NEURALAB LTD [US], et al) [X] 1-10,13-19*p.3, l.4-6" *;
 [X]WO2004024090  (UNIV CALIFORNIA [US], et al) [X] 1-10,13-19 *p.13, l.13-22* *p. 39, l.30-32* *p.44, l.5-19* * figure 3 *;
 [X]WO2004031400  (UNIV NORTHWESTERN [US], et al) [X] 1-10,13-19 *p.3, l.20-21* *p.6, l.30-31* *p.11, l.11-12* *p.23, l.12-14* *p.63, l.20-21* *p.84, l.19-33* *p.91, l.20-26* *p.94, l.20-p.95, l.2*;
 [X]DE10303974  (ABBOTT GMBH & CO KG [DE]) [X] 1-10,13-19 * page 7, paragraph 55 - paragraph 56 *
International search[X]JP2003509020  ;
 [X]JP2003517461  ;
 [X]JP2001247600  (MITSUBISHI CHEM CORP);
 [X]JP2002105099  (MITSUBISHI CHEM CORP);
 [X]  - LOMBARDO J.A. ET AL, "Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations", J. NEUROSCI., (2003), vol. 23, no. 34, pages 10879 - 10883, XP002999354
 [X]  - HOSHI M., "'Katachi' ga Seigyo suru Shinkei no Shi", PROTEIN, NUCLEIC ACID AND ENZYME, 2004 NEN, 5 GATSU, (2004), vol. 49, no. 7, pages 1098 - 1100, XP002999355
 [Y]  - HOSHI M. ET AL, "Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta", PROC.NATL.ACAD.SCI. USA, (2003), vol. 100, no. 11, pages 6370 - 6375, XP002999356

DOI:   http://dx.doi.org/10.1073/pnas.1237107100
 [Y]  - HOSHI M., "beta-amyloid Jiko Soshikika ni yoru Shinkei Dokusei no Hatsugen", CHEMISTRY & CHEMICAL INDUSTRY, 2004 NEN, 5 GATSU,, (2004), vol. 57, no. 5, pages 519 - 521, XP002999357
by applicant   - DESHPANDE A ET AL., J. NEUROSCI., (2006), vol. 45, no. 51
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.